SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
ADLERZ CLIFFORD G

(Last) (First) (Middle)
40 BURTON HILLS BOULEVARD
SUITE 500

(Street)
NASHVILLE TN 37215

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SYMBION INC/TN [ SMBI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and COO
3. Date of Earliest Transaction (Month/Day/Year)
08/23/2007
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/23/2007 D 223,745 D(1) $22.35 0 D
Common Stock 08/23/2007 D 3,172 D(1) $22.35 0 I by trust
Common Stock 08/23/2007 D 40,298 D(2) $22.35 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options $18.32 08/23/2007 D 32,000 (3) 01/18/2014 Common Stock 32,000 (4) 0 D
Stock Options $23.8 08/23/2007 D 50,000 (3) 02/27/2016 Common Stock 50,000 (5) 0 D
Stock Options $19.26 08/23/2007 D 50,000 (3) 01/05/2015 Common Stock 50,000 (4) 0 D
Stock Options $19.7 08/23/2007 D 50,000 (3) 12/10/2014 Common Stock 50,000 (4) 0 D
Stock Options $13.87 08/23/2007 D 108,344 (3) 05/16/2012 Common Stock 108,344 (4) 0 D
Stock Options $15 08/23/2007 D 69,972 (3) 12/11/2013 Common Stock 69,972 (4) 0 D
Explanation of Responses:
1. Disposed of in connection with the merger of Symbol Merger Sub, Inc. with and into Symbion, Inc. ("Symbion"), effective August 23, 2007 (the "Merger"), pursuant to the Agreement and Plan of Merger dated April 24, 2007 among Symbol Acquisition, L.L.C., Symbol Merger Sub, Inc. and Symbion. In connection with the Merger, the shares listed were exchanged for the right to receive $22.35 per share in cash.
2. Disposed of in connection with the Merger. The shares listed were exchanged for an equity interest in Symbion Holdings Corporation. In connection with the Merger, the common stock of Symbion was valued at $22.35 per share.
3. Immediately before the effective time of the Merger, all unvested options became fully vested and immediately exercisable.
4. This option was replaced with a new substitute option at the time of the Merger with an exercise price of $1.50 per share and calculated in a manner that satisfies the substitution requirements of Section 409A of the Internal Revenue Code.
5. All options with an exercise price above the merger consideration of $22.35 per share were cancelled in the Merger and no payment will be made thereon.
/s/ Clifford G. Adlerz 08/23/2007
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.